首页> 外文OA文献 >Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo
【2h】

Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo

机译:在体内消耗CD8 + T细胞的小鼠中跨I类主要组织相容性障碍的皮肤同种异体移植排斥的细胞基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study was undertaken to define the cellular mechanisms involved in the rejection of major histocompatibility complex (MHC) class I disparate skin grafts by mice depleted of CD8+ T cells in vivo. Mice were effectively depleted of CD8+ T cells by adult thymectomy followed by in vivo administration of anti-CD8 monoclonal antibody (mAb) and then engrafted with allogeneic skin. We found that CD8 depleted mice did reject MHC class I disparate skin grafts, but only when the grafts also expressed additional alloantigens. Despite the marked depletion of CD8+ T cells in these mice, we found that their rejection of MHC class I disparate grafts was mediated by CD8+ cytolytic T lymphocyte (CTL) effectors that had escaped depletion. These CD8+ CTL effectors were unique in that: (a) their generation was dependent upon the injected anti-CD8 mAb and upon exposure to class I MHC alloantigens expressed on the engrafted skin, and (b) their effector function was resistant to blockade by anti-CD8 mAb. We observed that the additional alloantigens coexpressed on MHC class I disparate grafts that triggered graft rejection in CD8-depleted mice could be MHC-linked or not and that they functioned in these rejection responses to activate third party specific CD4+ T helper (Th) cells to provide helper signals for the generation of CD8+ anti-CD8 resistant CTL effector cells. Thus, mice depleted of CD8+ T cells by thymectomy and in vivo administration of anti-CD8 mAb harbor a unique population of anti-CD8 resistant, CD8+ effector cells that mediate anti-MHC class I responses in vivo and in vitro, but require help from third party specific Th cells to do so.
机译:进行本研究以定义参与体内耗竭CD8 + T细胞的小鼠排斥主要组织相容性复合体(MHC)I类异种皮肤移植物的细胞机制。通过成人胸腺切除术,然后在体内施用抗CD8单克隆抗体(mAb),然后同种异体皮肤移植,可有效去除小鼠的CD8 + T细胞。我们发现,耗竭CD8的小鼠确实拒绝了MHC I类完全不同的皮肤移植物,但是只有当该移植物还表达了其他同种异体抗原时才如此。尽管这些小鼠中的CD8 + T细胞明显耗竭,但我们发现它们对MHC I类异种移植物的排斥反应是由逃避耗竭的CD8 +溶细胞性T淋巴细胞(CTL)效应子介导的。这些CD8 + CTL效应子的独特之处在于:(a)它们的产生取决于所注射的抗CD8 mAb和暴露于移植皮肤上表达的I类MHC同种抗原,并且(b)其效应子功能可抵抗抗-CD8单克隆抗体。我们观察到,在MHC I类完全不同的移植物中共表达的其他同种异体抗原可以触发或不与MHC相关联,从而触发CD8耗竭的小鼠中的移植排斥,并且它们在这些排斥反应中起作用,以激活第三方特异性CD4 + T辅助(Th)细胞为CD8 +抗CD8抗性CTL效应细胞的产生提供辅助信号。因此,通过胸腺切除术和体内施用抗CD8 mAb耗尽了CD8 + T细胞的小鼠具有独特的抗CD8抗性CD8 +效应细胞群,可在体内和体外介导抗MHC I类反应,但需要获得帮助第三方特定的Th细胞可以这样做。

著录项

  • 作者

  • 作者单位
  • 年度 1991
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号